Cargando…

Elafin: a double agent in breast and ovarian cancer

Detalles Bibliográficos
Autores principales: Feng, Yi, Doberstein, Kai, Drapkin, Ronny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671923/
https://www.ncbi.nlm.nih.gov/pubmed/26682248
_version_ 1782404469014659072
author Feng, Yi
Doberstein, Kai
Drapkin, Ronny
author_facet Feng, Yi
Doberstein, Kai
Drapkin, Ronny
author_sort Feng, Yi
collection PubMed
description
format Online
Article
Text
id pubmed-4671923
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-46719232015-12-17 Elafin: a double agent in breast and ovarian cancer Feng, Yi Doberstein, Kai Drapkin, Ronny Oncoscience Editorial Impact Journals LLC 2015-09-17 /pmc/articles/PMC4671923/ /pubmed/26682248 Text en Copyright: © 2015 Feng et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Feng, Yi
Doberstein, Kai
Drapkin, Ronny
Elafin: a double agent in breast and ovarian cancer
title Elafin: a double agent in breast and ovarian cancer
title_full Elafin: a double agent in breast and ovarian cancer
title_fullStr Elafin: a double agent in breast and ovarian cancer
title_full_unstemmed Elafin: a double agent in breast and ovarian cancer
title_short Elafin: a double agent in breast and ovarian cancer
title_sort elafin: a double agent in breast and ovarian cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671923/
https://www.ncbi.nlm.nih.gov/pubmed/26682248
work_keys_str_mv AT fengyi elafinadoubleagentinbreastandovariancancer
AT dobersteinkai elafinadoubleagentinbreastandovariancancer
AT drapkinronny elafinadoubleagentinbreastandovariancancer